Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
This is off-label use currently, but the data is compelling enough that it deserves consideration for appropriate patients
Br a gygyszer hatkony segtsget jelenthet, a hossz tv eredmnyek szempontjbl tovbbra is meghatroz szerepe van a megfelel tpllkozsnak, a rendszeres mozgsnak s az letmdbeli szoksoknak
Comparison with other GLP-1 medications *Yellow Card reporting data based on MHRA Yellow Card scheme trend analysis and may not reflect exact current figures Key points: Headache frequency on Mounjaro About 1 in 12 UK patients experience headaches on Mounjaro Headache rates are similar to placebo in clinical trials Headaches are less common than digestive side effects Most headaches are temporary, lasting 2-4 weeks Mounjaro has slightly lower headache rates than other GLP-1 medications Preventing Mounjaro-related headaches You can take several proactive steps to reduce your risk of developing headaches while taking Mounjaro: Hydration strategies Water intake is critical for preventing Mounjaro-related headaches
Type 1 diabetes patients have reported rare but serious DKA events while on GLP-1 agonists, sometimes with atypical low glucose levels
Acute liver injury, acute kidney injury, and pancreatitis were not reported in any patients
ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis
